A detailed history of Two Sigma Securities, LLC transactions in Bio Cardia, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 111,079 shares of BCDA stock, worth $326,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,079
Holding current value
$326,572
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.38 - $0.68 $42,210 - $75,533
111,079 New
111,079 $45,000
Q1 2022

May 16, 2022

SELL
N/A
-21,196 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
N/A
21,196 New
21,196 $41,000

Others Institutions Holding BCDA

About BioCardia, Inc.


  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $52.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.